)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Looking back, moving on: Doctors, nurses, ambulance drivers say Covid-19 has left them life-altering lessons
With this agreement, India will become the first global territory where Centhaquin (Lyfaquin) is being launched immediately, according to the company
The FMRAI had in 2021, lodged a case in the Supreme Court of India to make the UCPMP a statutory law
In November 2023, Aster DM had received corporate approvals to separate its India and Gulf Cooperation Council (GCC) businesses into two distinct and standalone entities
The tech transfer will be completed by 2025 and the vaccine will be manufactured for India and international markets by Biological E
While gamma knife surgeries are usually used to treat brain tumours, AIIMS New Delhi claims to be the only institution in India to perform it for treating intraocular tumours
According to the NCH notification, each existing institution will now have to submit information and relevant annexures needed for the assessment and rating on an annual basis
A key task of the committee is to suggest measures to prevent fraud or misuse of the scheme
According to the report, 21 per cent of these companies' spending in R&D was dedicated towards environmental and social activities
Industry insiders expressed concerns around how the new UCPMP would be implemented and how anyone found guilty of violations of the code would be penalised
Medical representatives barred from using 'inducement' or 'subterfuge' to access healthcare professionals
Drug manufacturers with annual turnovers below Rs 500 crore will get the financial assistance in upgrading their facilities to meet global standards
Financial support for drug companies also comes against the backdrop of deaths being reported abroad due to the manufacture of substandard drugs linked to Indian companies
Traditional brain surgeries last three to four hours, ZAP-X completes treatment within a single session lasting no more than 30 minutes, John R Adler, founder and CEO of Zap Surgical said
Last year, GQG Partners had acquired shares of hospital chain Max Healthcare Institute in a bulk deal for Rs 415 crore through an open market transaction
Company aims to capture 60-70% of disposable syringes market in India
The participation aims to add to the diagnostic service provider's international portfolio. Its international network consists of several centres and pick-up points (PUPs) across multiple locations
The ministry on Monday tied up with the Indian Council of Medical Research (ICMR) to conduct the study, which aims at backing up Ayush treatment with scientific and evidence-based research
Union Minister of Chemical and Fertilisers Mansukh Mandaviya on Saturday inaugurated 40 greenfield facilities to manufacture bulk drugs and medical devices under the PLI scheme
The market for Vitamin B12 supplements is expanding, according to data from clinical research agency IQVIA.